Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
17.26
-0.09 (-0.52%)
Jul 27, 2026, 1:10 PM EDT - Market open
Sotera Health Company Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,189 | 1,164 | 1,100 | 1,049 | 1,004 | 931.48 |
Revenue Growth | 7.44% | 5.74% | 4.88% | 4.54% | 7.75% | 13.85% |
Gross Profit Gross Profit Growth | 657.17 | 645.53 | 602.3 | 577.16 | 557 | 518.67 |
Operating Income Operating Income Growth | 380.82 | 362.03 | 297.63 | 276.69 | 248.35 | 256.73 |
Net Income Net Income Growth | 117.8 | 77.95 | 44.4 | 51.38 | -233.57 | 116.88 |
Earnings Per Share EPS Growth | 0.41 | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 |
EPS Growth | 412.50% | 68.75% | -11.11% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Sterigenics Sterigenics Growth | 772.23 | 755.78 | 697.85 | 667.13 | 626.65 | 571.83 |
Nordion Nordion Growth | 197.07 | 187.62 | 173.36 | 160.46 | 153.64 | 140.51 |
Nelson Labs Nelson Labs Growth | 219.84 | 220.22 | 229.23 | 221.7 | 223.4 | 219.14 |
Revenue (Total) Revenue (Total) Growth | 1,189 | 1,164 | 1,100 | 1,049 | 1,004 | 931.48 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 315.95 | 346.46 | 278.87 | 301.65 | 396.29 | 106.92 |
Total Debt Total Debt Growth | 2,270 | 2,274 | 2,351 | 2,327 | 2,032 | 1,828 |
Net Cash (Debt) Net Cash Growth | -1,954 | -1,927 | -2,072 | -2,025 | -1,636 | -1,721 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -6.81 | -6.73 | -7.27 | -7.15 | -5.84 | -6.16 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 261.11 | 287.2 | 224.16 | -147.73 | 277.96 | 281.55 |
Capital Expenditures CapEx Growth | -164.27 | -138.02 | -179.07 | -214.98 | -182.38 | -102.16 |
Free Cash Flow Free Cash Flow Growth | 96.84 | 149.18 | 45.09 | -362.71 | 95.58 | 179.38 |
Free Cash Flow Growth | -8.54% | 230.81% | - | - | -46.72% | 167.42% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 55.26% | 55.48% | 54.73% | 55.00% | 55.50% | 55.68% |
Operating Margin | 32.02% | 31.11% | 27.05% | 26.37% | 24.74% | 27.56% |
Pretax Margin | 17.23% | 12.68% | 10.35% | 10.10% | -24.22% | 18.86% |
Profit Margin | 9.91% | 6.70% | 4.03% | 4.90% | -23.27% | 12.57% |
FCF Margin | 8.14% | 12.82% | 4.10% | -34.57% | 9.52% | 19.26% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 42.48 | 65.33 | 85.50 | 93.61 | - | 57.44 |
Forward PE | 17.64 | 19.12 | 18.03 | 18.81 | 8.38 | 24.18 |
P/FCF Ratio | 50.85 | 33.63 | 85.99 | - | 24.61 | 37.15 |
PS Ratio | 4.14 | 4.31 | 3.52 | 4.54 | 2.34 | 7.15 |